Aditya Bardia
Assistant Professor, Medicine at Harvard Medical School
Biography
Harvard Medical School
Dr. Bardia is a board-certified medical oncologist interested in developing successful targeted and personalized therapies to improve the outcomes of patients and families afflicted with breast cancer. The accurate identification of target is crucial for success of targeted therapies, and Dr. Bardia is involved in the clinical development of tumor genotyping as well as circulating tumor cells (CTCs) to facilitate accurate diagnosis, therapy selection, and real-time monitoring of breast cancer. In collaboration the CTC center and Haber lab, his research on molecular changes in CTCs in metastatic breast cancer has elucidated the role of epithelial-mesenchymal transition, and provided proof-of-principle that ex-vivo CTC culture and molecular drug testing is feasible in breast cancer. Dr. Bardia is the principal investigator of clinical trials investigating the role of targeted therapy combinations for breast cancer. Dr. Bardia is the recipient of Young Investigator Award from the ASCO Conquer Cancer Foundation.
Clinical Interests:
- Breast Cancer
- Targeted therapies
Medical Education
- MBBS, All India Institute of Medical Sciences
- MPH, University of Iowa College of Public Health
- Residency, ALL INDIA INSTITUTE OF MEDICAL SCIENCES
- Residency, Mayo Clinic
- Fellowship, Johns Hopkins Hospital
Videos
Dr. Aditya Bardia on RAD1901 in ER-Positive Metastatic Breast Cancer
Dr. Bardia on Sacituzumab Govitecan in Triple-Negative Breast Cancer
Read about executive education
Other experts
Popular Courses
Private Equity: Investing and Creating Value
The Wharton School
Philadelphia, Pennsylvania, United States
Feb 2, 2025
The Positive Leader: Deep Change and Organizational Transformation
Stephen M. Ross School of Business
Ann Arbor, Michigan, United States
Sep 29
Leading People and Teams
ESMT
Berlin, Germany
Nov 19
Looking for an expert?
Contact us and we'll find the best option for you.